Microsoft India Profit Jumps 38.66% in FY25
Microsoft India reports impressive 38.66% profit growth reaching ₹1,245.18 crore in FY2025. Revenue surges 28% to ₹29,303 crore. Discover the key factors behind this stellar performance.
Category : Search result: pharmaceutical company profit
Remedium Lifecare Q2 Profit Jumps 92% to ₹38.62 Cr
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
Evexia Lifecare Share Price Rises 3% on High Volumes
Evexia Lifecare share price gained over 3% with heavy trading volumes. Discover the Q2 FY26 results showing a sharp profit fall and the stock's long-term decline. Read analysis before investing.
Novo Nordisk brings back former CEO as chairman
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Hvax Technologies H1 FY26 Income Jumps 35%
Hvax Technologies announces impressive 35% growth in total income for H1 FY26, reaching ₹5.95 crore. The company shows strong financial performance with significant profit improvements.
Punjab Health Minister's Stern Warning to Drug Manufacturers
Punjab Health Minister Dr Balbir Singh issues strict quality warning to drug manufacturers after MP cough syrup incident. State adopts zero-tolerance policy on sub-standard medicines.
India Urges Russia to Fast-Track Export Approvals
India requests Russia to expedite approvals for Indian exporters in marine, pharmaceutical sectors during Moscow talks. Bilateral trade targets $100B by 2030. Key discussions ahead of Putin's December visit.
FSSAI bans misleading ORS ads, FDC's Electral validated
FSSAI cracks down on false ORS marketing claims. FDC Ltd welcomes action, reaffirming Electral's 50-year scientific legacy as genuine electrolyte solution.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
India Pushes Russia for Faster Approvals to Boost Trade
India urges Russia to expedite approvals for marine and pharmaceutical products during Moscow talks. Bilateral trade currently at $25 billion, targeting $100 billion by 2030.
Bry-Air Launches P80X MOF Dehumidifier for Pharma
Bry-Air introduces P80X, the most advanced MOF-technology dehumidifier for pharmaceutical manufacturing. Ensures precise humidity control for quality compliance.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Bharuch's Saykha GIDC leaves 2 workers dead, 20 injured. Fire brigade and investigation teams on site. Read latest updates.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
FDA Names Dr. Richard Pazdur as New Drug Center Director
The FDA appoints veteran cancer regulator Dr. Richard Pazdur to lead its drug center following the ouster of Dr. George Tidmarsh over ethics concerns. Learn about the challenges ahead.
Granules India Gets USFDA Approval for Hyderabad Plant
Granules Life Sciences receives USFDA approval for new Hyderabad facility to manufacture diabetes drug Metformin HCL. Capacity: 10 billion tablets annually. Read more about this pharmaceutical milestone.
Hindustan Copper Q2 profit jumps 85% to ₹186 crore
State-owned Hindustan Copper reports impressive 85% surge in Q2 FY26 net profit reaching ₹186.02 crore, driven by robust income growth. Discover the key financial highlights and operational insights.
String Metaverse Q2 FY26: Revenue Up 213.49%, Profit 229.12%
String Metaverse Ltd reports explosive Q2 FY26 growth with 213.49% revenue surge and 229.12% profit increase. Discover how the metaverse company achieved these remarkable results.
Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
DCGI Orders Global Pharma Standards Implementation by Jan 2026
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Elitecon International Q2 Sales Jump 538%, PAT Doubles
Elitecon International delivers spectacular Q2 FY2026 performance with 538% sales surge and doubled profits, showcasing remarkable growth trajectory in international markets.
Mitsu Chem Plast Q2 Profit Jumps 66%
Mitsu Chem Plast Limited reports outstanding Q2 FY26 results with 66% net profit growth and 11% revenue increase, showcasing robust financial health and operational excellence.
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Curis Lifesciences IPO: 17x Subscription on Day 1
Curis Lifesciences' NSE SME IPO witnesses massive investor response with 17.36 times subscription on Day 1. Discover GMP trends, price band details, and why this pharma stock is creating buzz.
Pharma Executive Collapses in Oval Office During Trump Meeting
A high-stakes White House meeting on weight-loss drug prices took a dramatic turn when a pharmaceutical executive suddenly collapsed, forcing an abrupt end to Donald Trump's briefing. The viral video has sparked nationwide concern.
Trump: Deal Reached to Lower Weight Loss Drug Prices
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
Big Pharma Cuts Obesity Drug Prices After Trump Pressure
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Birlasoft Q2 Profit Falls 9%, Declares ₹2.50 Dividend
Birlasoft reports mixed Q2 FY2024 results with 9% drop in net profit but declares interim dividend. Revenue shows modest growth while margins face pressure.
Page 1 of 4